etectRx
D. Eric Buffkin Jr. is a repeat entrepreneur and executive with more than 25 years of experience launching ventures in the tech and health-tech industries. Along with Dr. Neil Euliano, he co-founded eTect Inc., the predecessor to etectRx™, in 2009. He is also the founder of Pelagic Group, a consultancy focused on enabling new technology companies with early stage capital, strategy, and executive guidance. Mr. Buffkin has served in executive roles with Intellon Corporation (now part of Qualcomm) and Motorola. He is the holder of three issued and multiple pending patents.
Mr. Buffkin holds a BSEE from the University of Florida and an MBA from Rollins College, Winter Park, Florida.
etectRx
etectRx™, Inc. is a Digital Health company that has developed a patented ingestible event marker (the ID-Cap™ System) that provides real-time, dose-level ingestion event verification. The ID-Cap System can be used by patients, healthcare providers, health systems, payers, and research organizations to track ingestion events and to measure, monitor and improve medication adherence and can also be used by pharmaceutical companies to develop Digital Medicine.